Image-guided therapy

Coronary suite

Transforming complex PCI procedures into confident cardiac care

Philips coronary artery disease (CAD) solutions consist of advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, working together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance and efficiency today while serving as your launching pad to the future and keeping you close to the heart of CAD.

Improving cath lab performance while staying close to the heart

In the complex cath lab landscape you need to know your path in advance. Philips offers a fully integrated ecosystem designed to meet today’s challenges and provide you with more information faster. This enhances cath lab performance, supporting confident decisions and exceptional patient care. Our CAD solutions work together to help you provide quick, confident diagnosis, along with effective, efficient treatment – ultimately contributing to improved outcomes¹.

Download

Azurion 7 M12 - the heart of our solution for cardiac care

Proven to reduce procedure time by 17%² by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.

Dynamic Coronary Roadmap - find your path

Find the right path and improve PCI outcomes. This Philips exclusive solution offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent use by 28.8%³.

IntraSight - when every tiny move matters

Philips IntraSight offers you a comprehensive suite of clinically proven^4-8 imaging, physiology and co-registration⁹ tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies.

Enabling technologies for Coronary suite

ClarityIQ Technology
ClarityIQ technology delivers significantly lower dose across the clinical area, patients, and operators.
IntraSight Interventional Applications Workspace
The Philips IntraSight Interventional Applications Platform is built for today's cath lab. Offers imaging and physiology tools with iFR, IVUS ...
iFR coronary physiology
Learn how you can guide PCI by using iFR index with coronary physiology for measuring pressure in diagnostic & interventional procedures.
Azurion with FlexArm
FlexArm ceiling-mounted system provides unlimited imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams.

Related procedures

Percutaneous coronary intervention
Advance percutaneous coronary interventions with imaging solutions, IVUS and real-time fluoroscopy for precise diagnosis and treatment.
Low contrast PCI procedures
Explore the different challenges seen in complex percutaneous coronary intervention (PCI) cases and how Philips’ specialty tools can help.

Footnotes

Coronary IVUS Technologies Intravascular imaging improves outcomes and reduces death Stone G, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Published Online February 21, 2024 https://app.contentful.com/spaces/fzjlyokyl1wq/environments/master/entries/5H9mL1ltYniTWMm296g289
Philips whitepaper 12nc 4522 991 30501;Reduction of procedure time by 17% with Philips Azurion in independently verified study; Philips Azurion Lab Performance Study. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4 Contrast trial www.documents.philips.com/assets/20240219/0e2a77c4a6904c6eaae3b11b00df6861.pdf
Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.
Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017.
Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503.
Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardiovascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.
Co-registration tools available within IntraSight 7 configuration via SyncVision

Disclaimer

Always read the label and follow the directions for use.

Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.

Products subject to country availability. Please contact your local sales representative.

Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.